Drug Utilisation Studies
Drug utilisation studies examine the marketing, distribution, prescription and use of drugs in a society, with special emphasis on the resulting medical, social and economic consequences (WHO).
Drug utilisation studies can form an important part of the risk management plan for a product, enabling the following information to be captured from real life clinical practice:
- Characteristics of users
- Indications for use
- Dosing regime
- Concomitant medication use
- Potential off-label use
Drug utilisation studies are frequently included in Risk Management Plans. The DSRU has extensive experience in advising on and conducting such studies. Our capabilities include:
- Production of a protocol considering regulatory requirements for study
- Management of the study and analysis of data
- Interpretation of study results
- Production of interim and final study reports
- Publication of study results in peer reviewed journals
Compared to other pharmacoepidemiological methods, generally drug utilisation studies are relatively easier to conduct and deliver results earlier.
Please contact us for an informal discussion.
- Network of European Studies
- Studies in Specialist/Hospital care
- M-PEM (Modified Prescription-Event Monitoring Studies)
- Mental Health Products ECHO
- Nested Case-Control Studies
- Drug Utilisation Studies
- Pharmacoepidemiological databases